Why Ascendis Pharma (ASND) Stock is a Compelling Investment Case

Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Mid-Cap Growth Fund posted a return of 31.64% for the quarter, outperforming its benchmark, the Russell Midcap Growth Index which returned 30.26% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for investors to buy right now, which could be the biggest winners of the stock market crash.

In the said letter, Brown Advisory highlighted a few stocks and Ascendis Pharma A/S (NASDAQ:ASND) is one of them. Ascendis Pharma A/S (NASDAQ:ASND) manufactures pharmaceutical products. Year-to-date, Ascendis Pharma A/S (NASDAQ:ASND) stock lost 0.8% and on July 23rd it had a closing price of $140.42. Here is what Brown Advisory said:

“We added Ascendis to our biotech holdings during the quarter. The company’s TransCon platform shows promise in Phase I-III trials in the multibillion-dollar endocrinology market, and it could begin to show the same opportunity in oncology next year as trials progress into the clinical phase in 2021.”

30 Funniest Science Jokes, Puns, and Humor Quotes Ever


In Q1 2020, the number of bullish hedge fund positions on Ascendis Pharma A/S (NASDAQ:ASND)  stock decreased by about 13% from the previous quarter (see the chart here), so a number of other hedge fund managers don’t seem to agree with Ascendis’ growth potential. Our calculations showed that Ascendis Pharma A/S (NASDAQ:ASND)  isn’t ranked among the 30 most popular stocks among hedge funds.

The top 10 stocks among hedge funds returned 185% since the end of 2014 and outperformed the S&P 500 Index ETFs by more than 109 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Below you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.

Video: Top 5 Stocks Among Hedge Funds

At Insider Monkey we scour multiple sources to uncover the next great investment idea. Hedge fund sentiment towards Tesla reached its all time high at the end of 2019 and Tesla shares more than tripled this year. We are trying to identify other EV revolution winners, so we are checking out this under-the-radar lithium stock. We go through lists like the 10 most profitable companies in the world to pick the best large-cap stocks to buy. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. If you want to find out the best healthcare stock to buy right now, you can watch our latest hedge fund manager interview here. You can subscribe to our free enewsletter below to receive our stories in your inbox:

Disclosure: None. This article is originally published at Insider Monkey.